These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Experiences on the treatment of cerebral insufficiency and peripheral circulation disorders with the test preparation EP 50-100]. Bock KJ Med Welt; 1972 Feb; 23(8):273-5. PubMed ID: 5012543 [No Abstract] [Full Text] [Related]
44. [The place of a peripheral vasodilator agent in the treatment of shock states]. Lareng L; Jorda MF; Cathala B; Mathelin D Anesth Analg (Paris); 1974; 31(1):41-51. PubMed ID: 4210208 [No Abstract] [Full Text] [Related]
45. Quantitation of blood flow through the arteriovenous anastomoses in the intestine. Delaney JP Surg Forum; 1966; 17():333-4. PubMed ID: 5920949 [No Abstract] [Full Text] [Related]
46. [On several anti-hypertensive drugs with special reference to the association of dihydroergocristine, reserpine and clopamide]. Martinetti L; Lai G Arch Maragliano Patol Clin; 1970; 26(3):209-18. PubMed ID: 5002193 [No Abstract] [Full Text] [Related]
48. Preliminary results in the treatment of peripheral arteriopathies with a new pharmacologic substance: I-(2"pyrimidyl)4 piperonyl piperazine (ET 495). Royer RJ Bibl Cardiol; 1969; 26():174-9. PubMed ID: 5402343 [No Abstract] [Full Text] [Related]
49. Effect of treatment on the development of vascular lesions in the hypertensive rat. Griffith R; Hummel R Triangle; 1973; 12(2):75-82. PubMed ID: 4201007 [No Abstract] [Full Text] [Related]
50. [Internal therapy of peripheral arterial blood circulation disorders]. Bollinger A Schweiz Med Wochenschr; 1970 May; 100(18):774-7. PubMed ID: 4321949 [No Abstract] [Full Text] [Related]
51. [On the pathogenesis and drug therapy of the varicose syndrome]. Heim EB Wien Med Wochenschr; 1968 Jul; 118(27):617-24. PubMed ID: 4974019 [No Abstract] [Full Text] [Related]
52. [Sudden deafness of idiopathic appearance]. Van den Eeckhaut J Acta Otorhinolaryngol Belg; 1969; 23(4):345-54. PubMed ID: 4995888 [No Abstract] [Full Text] [Related]
53. [Attempt at psychometric evaluation of aging: study of a vascular drug]. Losson M; Losson JP Therapeutique; 1969 Mar; 45(3):313-7. PubMed ID: 4989246 [No Abstract] [Full Text] [Related]
54. [Interpretation of the clinical signs in the light of recent acquisitions]. Heyck H Minerva Med; 1968 Dec; 59(96):5200-6. PubMed ID: 4974812 [No Abstract] [Full Text] [Related]
55. [Can a hydergine therapy lead to damage of the coronary vessels?]. Müller FU Dtsch Med Wochenschr; 2002 Jun; 127(25-26):1401. PubMed ID: 12134783 [No Abstract] [Full Text] [Related]
57. [Trial of eutergine in chronic cerebral arteriopathies]. Pauchant M; Bernard JM Lille Med; 1972 May; 17():Suppl 4:819-23. PubMed ID: 4626797 [No Abstract] [Full Text] [Related]
58. [Therapy of cerebral ictus yesterday and today]. Giorgini R Minerva Med; 1974 Mar; 65(24):1316-21. PubMed ID: 4133959 [No Abstract] [Full Text] [Related]
59. [The use of sympatholytics (hydergine) in association with other drugs in the prevention and treatment of post-operative acute renal insufficiency]. Morra A; Pettinelli U Minerva Chir; 1970 Dec; 25(23):1600-6. PubMed ID: 4994489 [No Abstract] [Full Text] [Related]
60. [Therapy of headaches, including migraine]. von Albert HH; Marguth F Bibl Psychiatr Neurol; 1969; 139():152-8. PubMed ID: 5002864 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]